2020 Trends In Pharma Asset Licensing And Deal Terms: A Survey Of Key Decision-Makers Lain Anderson TJ Bilodeau Read more
Related Practice Life Sciences & Pharma In this article, we describe some key drivers of asset value, as well as areas of alignment and divergence between parties on deal expectations. 01052021090143
Article Healthcare Services The LatAm Digital Landscape in Healthcare: Where Are the Opportunities Today? April 25, 2023
Executive Insights Life Sciences & Pharma Clinical Trial Challenges: Patient Recruitment and Diversity March 11, 2023
Podcast Contract/Pharma Services L.E.K. Consulting’s Inaugural Clinical and eClinical Pharma Services Survey February 28, 2023
Executive Insights Biotech and Pharmaceuticals Building Clinical Trial Leadership in Biopharma October 5, 2022